Updates are available Correction dated 2019-02-08
Click to view Correction: https://doi.org/10.1038/s41589-019-0233-6
-
Authors
Ma, Honghui
Wang, Xiaoyun http://orcid.org/0000-0002-3000-6441
Cai, Jiabin
Dai, Qing http://orcid.org/0000-0002-8578-1568
Natchiar, S. Kundhavai
Lv, Ruitu
Chen, Kai
Lu, Zhike
Chen, Hao http://orcid.org/0000-0002-2534-9650
Shi, Yujiang Geno
Lan, Fei
Fan, Jia
Klaholz, Bruno P.
Pan, Tao
Shi, Yang
He, Chuan http://orcid.org/0000-0003-4319-7424
- License Information
-
More Information
Article History
Received: 10 August 2017
Accepted: 30 October 2018
First Online: 10 December 2018
Change Date: 8 February 2019
Change Type: Correction
Change Details: In the version of this article originally published, the references were incorrectly re-ordered during production. The hyphen in “<i>N</i><sup>6</sup>-methyladenosine” in the title was also superscript. The errors have been corrected in the HTML and PDF versions of the paper.
Competing interests
: Y.S. is a co-founder of Constellation Pharmaceuticals, Inc., and Athelas Therapeutics. C.H. is a scientific founder of Accent Therapeutics, Inc. and a member of its scientific advisory board.
